APcK110
Product Specifications
CAS Number
1001083-74-4
Target
Others|||c-Kit
Related Pathways
Tyrosine Kinase/Adaptors|||Others
Bioactivity
APcK110 is a novel Kit inhibitor . APcK110 inhibits proliferation of the mastocytosis cell line HMC1.2 and the SCF-responsive cell line OCI/AML3 in a dose-dependent manner . APcK110 is a more potent inhibitor of OCI/AML3 proliferation than the clinically used Kit inhibitors imatinib and dasatinib and at least as potent as cytarabine. APcK110 inhibits the phosphorylation of Kit, Stat3, Stat5, and Akt in a dose-dependent fashion, showing activity of APcK110 on Kit and its downstream signaling pathways . APcK110 may have potent application in AML.
Smiles
FC1=CC=C(C=2C=3C(=NC(=CC3)C4=CC(OC)=CC(OC)=C4)NN2)C=C1
Molecular Formula
C20H16FN3O2
Molecular Weight
349.36
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/34D171E9-ED36-4570-B317-B3AA8BB4755B/T71654
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15297358 1 Vial
Lentiviral mouse Setd4 shRNA (UAS) - Lentiviral mouse Setd4 shRNA (UAS) plasmid
Ask
View Details ![N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-L-proline](https://cdn.genprice.uk/products/572/6314612386468/imageurl/trc-h296965-250mg.webp)
